U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 18,580
-230 (-1.22%)
At close: Apr 9, 2026
U2Bio Revenue
In the year 2025, U2Bio had annual revenue of 25.59B KRW with 2.21% growth. U2Bio had revenue of 6.27B in the quarter ending December 31, 2025, with 0.11% growth.
Revenue
25.59B
Revenue Growth
+2.21%
P/S Ratio
11.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
294.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.59B | 552.73M | 2.21% |
| Dec 31, 2024 | 25.04B | -5.75B | -18.68% |
| Dec 31, 2023 | 30.79B | -38.22B | -55.38% |
| Dec 31, 2022 | 69.01B | 58.01B | 527.29% |
| Dec 31, 2014 | 11.00B | 1.59B | 16.90% |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seohee Construction | 1.10T |
| Huons | 620.77B |
| Cape Industries | 579.77B |
| Pond Group | 485.57B |
| GOLFZON | 483.26B |
| KHVATEC | 424.90B |
| Smec Co.,Ltd | 153.59B |
| ASICLAND | 72.85B |